全文获取类型
收费全文 | 184篇 |
免费 | 8篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 5篇 |
妇产科学 | 13篇 |
基础医学 | 21篇 |
口腔科学 | 2篇 |
临床医学 | 17篇 |
内科学 | 47篇 |
皮肤病学 | 1篇 |
神经病学 | 17篇 |
特种医学 | 6篇 |
外科学 | 25篇 |
综合类 | 2篇 |
预防医学 | 2篇 |
眼科学 | 2篇 |
药学 | 15篇 |
肿瘤学 | 19篇 |
出版年
2023年 | 2篇 |
2022年 | 3篇 |
2021年 | 13篇 |
2020年 | 9篇 |
2019年 | 4篇 |
2018年 | 5篇 |
2017年 | 4篇 |
2016年 | 8篇 |
2015年 | 3篇 |
2014年 | 8篇 |
2013年 | 5篇 |
2012年 | 16篇 |
2011年 | 18篇 |
2010年 | 9篇 |
2009年 | 7篇 |
2008年 | 11篇 |
2007年 | 16篇 |
2006年 | 21篇 |
2005年 | 12篇 |
2004年 | 9篇 |
2003年 | 3篇 |
2002年 | 4篇 |
2001年 | 1篇 |
2000年 | 1篇 |
1996年 | 2篇 |
1982年 | 1篇 |
排序方式: 共有195条查询结果,搜索用时 0 毫秒
191.
192.
193.
Bolotin G Raman J Williams U Bacha E Kocherginsky M Jeevanandam V 《Asian cardiovascular & thoracic annals》2007,15(6):463-467
Myocardial ischemia-reperfusion injury is common during cardiac procedures. Glutamine may protect the myocardium by preserving metabolic substrates. Glutamine (0.52 g x kg(-1)) or Ringer's lactate solution (control group) was administered intraperitoneally to 63 Sprague-Dawley rats at 4 or 18 hours prior to experimental ischemia and reperfusion. The hearts were excised and perfused on an isolated working heart model, exposed to global ischemia for 15 min and reperfusion for 1 hour. Left atrial pressure, mean aortic pressure, cardiac flow, coronary flow, and aortic output were measured 15 min before ischemia and every 15 min during reperfusion. There was significantly better cardiac output in the glutamine pretreated groups. Pretreatment at 4 hours before the experiment was superior to pretreatment at 18 hours, with better maintenance of cardiac output and coronary flow. The enhanced protective effect of pretreatment at 4 hours highlights the importance of timing, and suggests a potential clinical benefit. 相似文献
194.
Lam MS 《The Annals of pharmacotherapy》2006,40(11):2048-2052
195.
Angela H. Kim AB Masha Kolesnikova BS Wei Kiong Ngo MD Stephen H. Tsang MD PhD 《Clinical & experimental ophthalmology》2023,51(3):205-216
Hypoxia-inducible factor (HIF) plays a critical role in the mechanisms that allow cells to adapt to various oxygen levels in the environment. Specifically, HIF-1⍺ has shown to be widely involved in cellular repair, survival, and energy metabolism. HIF-1⍺ has also been found in increased levels in cancer cells, highlighting the importance of balance in the hypoxic response. Promoting HIF-1⍺ activity as a potential therapy for degenerative diseases and inhibiting HIF-1⍺ as a therapy for pathologies with overactive cell proliferation are actively being explored. Digoxin and metformin, HIF-1⍺ inhibitors, and deferoxamine and ⍺-ketoglutarate analogues, HIF-1⍺ activators, are being studied for application in age-related macular degeneration, diabetic retinopathy, and retinitis pigmentosa. However, these same medications have retinal toxicities that must be assessed before implementation of therapeutic care. Herein, we highlight the duality of therapeutic and toxic potential of HIF-1⍺ that must be carefully assessed prior to its clinical application in retinal disorders. 相似文献